Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-07

Clinical Trial Update: Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing clozapine to chlorpromazine for treatment-unresponsive schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOZARIL (Clozapine)
  • Thorazine (Chlorpromazine hydrochloride)

Snippet

Sponsor: Harvard Medical School (HMS and HSDM) | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED